Skip to main content


Onkotrakt works together with leading pharmaceutical companies, research institutes, laboratories, and renowned researchers in order to scientifically analyze the real-world data collected during the existing projects and make them available to a broad group of interested parties. 
Onkotrakt has a dedicated expert committee that oversees project development and provides scientific advice. The scientific advisory council continuously reviews the necessary input parameters as well as the plausibility and completeness of the data in ongoing projects. Advice on new project ideas – from the feasibility study and practical implementation through to publication of the results – is obtained from oncologists who are actively involved in patient care.